Lokalizacja szczepu wirusa HVT FC126 w narzadach wewnetrznych kurczat szczepionych przeciwko chorobie Mareka

• Autorzy: Samorek-Salamonowicz E , Czekaj H. , Kozdrun W. , Krol K.

Warianty tytułu

EN

Localization of the HVT FC 126 virus strain in internal organs of chickens vaccinated against Marek's disease

• Języki publikacji: PL

Abstrakty

EN

The aim of this study was a comparison of the occurrence and presence of Mareks disease strain HVT FC 126 in internal organs after in ovo vaccination and after vaccination of one day old chicks. One hundred SPF chicken embryos were used in the experiment on the 18th day of incubation. Forty-five embryos were vaccinated in ovo with a dose of 2400 pfu of virus HVT FC 126. Twenty-eight embryos were injected in the back area (group I), and for 17 embryos the vaccine was provided to the embryonic fluids (group II). All of the embryos were hatched. Chicks from non-vaccinated embryos were divided into two groups. On the first day after clutch, 30 chicks were vaccinated in the leg muscle (group III). The fourth control group consisted of non-vaccinated chicks. Blood samples and sections of the liver, spleen, kidneys, and bursa of Fabricius were taken on days 1, 3, 7 and 10 from 5-day-old chicks (group I), on days 1, 3 and 10 from group II, and on days 3, 7 and 10 from groups III and IV. Total DNA was extracted from the samples, and used for the detection of viral DNA with PCR method. For amplification, two primers, specific for the fragment of A gene of MDV 3 serotype were used. No influence of in ovo vaccination on hatching was observed. Percentage of hatched chicks after in ovo vaccination was 85.7% and in the control group 87.3%. Chicks were healthy and welldeveloped. Viral DNA was found in the blood and lungs in group I about 3 hours after hatching, and was detected on the third day of life in blood, liver, spleen, lungs and kidneys of birds from group I as well as in blood samples from group II. From the 7th day of life characteristic for HVT FC 126 product (434 bp) was observed in all the samples collected from group I. It was subsequently detected in blood, spleen and lungs on the 7th day of life and in the bursa of Fabricius and liver on the 10th day of life in group III. Viral DNA was not found in samples taken from the heart and kidneys.

Słowa kluczowe

PL

lokalizacja; kurczeta; wirus szczepionkowy; zwierzeta szczepione; szczepienia ochronne; herpeswirus indyczy FC126; metoda in ovo; drob; choroby zwierzat; immunoprofilaktyka; narzady wewnetrzne; choroba Mareka

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2007
• Tom: 63
• Numer: 07
• Opis fizyczny: s.827-830,fot.,tab.,bibliogr.

Twórcy

autor

Samorek-Salamonowicz E

• Panstwowy Instytut Weterynaryjny - Panstwowy Instytut Badawczy, Al.Partyzantow 57, 24-100 Pulawy

autor

Czekaj H.

autor

Kozdrun W.

autor

Krol K.

Bibliografia

• 1.Baines D.: Szczepienia in ovo w immunoprofilaktyce choroby Mareka i zakaźnego zapalenia torby Fabrycjusza. Mat. Symp. System INOVOJECT aktualne możliwości i perspektywy zastosowañ w praktyce drobiarskiej. Warszawa 1998, s. 21-23.
• 2.Becker Y., Asher Y., Tabor E., Davidson I., Malkinson M., Weisman Y.: Polymerase chain reaction for differentiation between pathogenic and non-pathogenic serotype 1 Marek's disease viruses (MDV) and vaccine viruses of MDV- -serotypes 2 and 3. J Virol. Methods 1992, 40, 307-322.
• 3.Davison F., Venugopal N.: Marek's Disease An Evolving Problem. Elsevier Accademic Press, Institute for Animal Helath, Compton Laboratory, UK 2004, s. 124.
• 4.Fabris G., Patarello J., Figarolli V.: In ovo Marek's vaccination. Europ. Poultry Conf., Glasgow 1994, s. 345-347.
• 5.Garcia-Camacho L., Schat K. A., Brooks R., Bounous D. I.: Early cell mediated immune responses to Marek's disease virus in the chickens lines with defined MHC. Vet. Immunol. Immunopathol. 2003, 95, 145-153.
• 6.Islam A. F. M., Waldken-Brown S. W., Wong C. W., Groves P. J., Burgess S. K., Arzey K. E., Young P. L.: Influence of vaccine deposition site on post-vaccinal viraemia and vaccine efficacy in broiler chickens following in ovo vaccination against Marek’s disease. Avian Pathol. 2001, 30, 525-533.
• 7.Miles A. M., Williams C. J., Womack C. L., Murray D. L., Gildersleeve R. P.: Commercial broilers studies of Marek's disease vaccination in ovo. Proc. of the XIX World's Congress, Amsterdam, September 20-24, 1992, s. 320-322.
• 8.Samorek-Salamonowicz E.: Choroba Mareka, [w:] Mazurkiewicz M. (red.): Choroby drobiu. Wyd. AR Wrocław 2005, s. 425.
• 9.Sarma G., Greer W., Gildersleeve R. P., Murray D. L., Miles A. M.: Field safety and efficacy of in ovo administration of HVT + SB 1 bivalent Marek's disease vaccine in commercial broilers. Avian Dis. 1995, 39, 211-217.
• 10.Schat K. A., Markovski-Grimsrud C. J.: Immune responses to Marek's disease virus infection. Curr. Top. Microbiol. Immunol. 2001, 255, 91-120.
• 11.Sharma J. M., Burmester B. R.: Resistance to Marek's disease at hatching in chickens vaccinated as embryos with the turkey herpesvirus. Avian Dis. 1982, 26, 134-149.
• 12.Walkden-Brown S. W., Islam A. F. M. F., Wong C. W., Burgess S. K., Groves P. J., Azrey E.: Vaccine deposition site influences the timing of post-vaccinal viremia following in ovo vaccination against Marek's disease (MD) in commercial broiler chickens. Proc. 6th Int. Symp. Marek’s disease, Montreal, Canada, August 20-23, 2000, s. 22-24.
• 13.Zhang Y., Sharma J. M.: Immunological tolerance in chickens hatching from eggs injected with cell associated herpesvirus of turkey (HVT). Dev. Comp. Immunol. 2003, 27, 431-438.